Compound Radar

Cellebrite DI Ltd. (CLBT) Stock Analysis

Price $11.45
Market cap $2.88B
Next earnings Nov 11, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

78
78/100 Elite Quality
  • Financial Health 85
  • Profitability 85
  • Business Quality 75
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 78/100 — Elite Quality

Strongest Financial Health 85/100
Softest Balance Sheet 65/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Cellebrite DI Ltd. (CLBT) is a Software - Infrastructure company in the Technology sector. Compound Radar rates Cellebrite DI Ltd. 78/100 (Elite Quality) due to high business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 49.78
  • Forward P/E 17.53
  • EV/Revenue 4.77

Profitability

  • Revenue Growth 15.8%
  • Gross Margin 83.0%
  • Operating Margin 5.3%
  • Net Margin 11.4%
  • ROE 12.4%

Financial strength

  • Cash $442.53M
  • Debt $23.23M
  • Net Cash $419.30M
  • Free Cash Flow $160.32M
  • Current Ratio 1.62

Similar companies

Peers in Software - Infrastructure, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Software - Infrastructure →

FAQ

How Compound Radar scores and tracks Cellebrite DI Ltd. (CLBT).

View Methodology & FAQ →